ImmunoGen: J. P. Morgan Healthcare Conference (35th Annual J.P. Morgan Healthcare Conference, Immunogen) - Jan 17, 2017 - Anticipated data from P1 trial (NCT02674763) in AML in mid-2017
Anticipated P1 data • Acute Myelogenous Leukemia • Hematological Malignancies • Oncology
|